Click it and Unblock the Notifications
For Quick Alerts
For Daily Alerts
Just In
Don't Miss
-
Robo Shankar's Daughter Indraja Reveals Reason For Thalapathy Vijay's Absence At Her Wedding -
Suzuki Access Electric To Electrify The Indian Scooter Market By 2024 -
Vodafone Idea Shares Soar 7% Following Strong FPO Subscription; GMP Hints Premium Shares; Details -
Infinix GT 20 Pro Schematic Shows Rear Panel Design; Expected to Launch on April 28 -
Chess: Who Is D Gukesh? Profile, Career, Achievements, ILO Rating & Mentor Details of FIDE Candidates Tournament 2024 Winner -
NBSE Nagaland board HSLC, HSSLC result 2024 to be released on April 26 at nbsenl.edu.in, Know more -
What Your Tongue Reveals About Your Health: Wellness And Warning Signs You Need To Know -
Kurnool's Hidden Gems: A Guide To Exploring India's Lesser-Known Treasures
Glenmark recieves US FDA approval for Ranitidine tablets
New Delhi, Nov 21 (UNI) Glenmark Pharmaceuticals Ltd today said it has received approval from the United States Food and Drug Administration (USFDA) for distribution and marketing of Ranitidine tablets in the US market.
Ranitidine tablets are used for treating duodenal and gastric ulcers and erosive esophagitis, the company said.
They
also
said
the
drug
would
be
available
in
tablet
form
in
the
strengths
of
150
mg
base
and
300
mg
base,
respectively
UNI
AK
SBC
ND1302
Comments
Story first published: Friday, November 21, 2008, 13:34 [IST]
